Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;18(1):39-47.
doi: 10.5223/pghn.2015.18.1.39. Epub 2015 Mar 30.

Laboratory markers indicating gastrointestinal involvement of henoch-schönlein purpura in children

Affiliations

Laboratory markers indicating gastrointestinal involvement of henoch-schönlein purpura in children

Jeana Hong et al. Pediatr Gastroenterol Hepatol Nutr. 2015 Mar.

Abstract

Purpose: To determine clinically useful biochemical markers reflecting disease activity and/or gastrointestinal (GI) tract involvement in Henoch-Schönlein purpura (HSP).

Methods: A total of 185 children with HSP and 130 controls were included. Laboratory data indicating inflammation, standard coagulation, and activated coagulation were analyzed for the HSP patients, including measurements of the hemoglobin level, white blood cell (WBC) count, absolute neutrophil count (ANC), platelet count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, prothrombin time, activated partial thromboplastin time, and fibrinogen, D-dimer, and fibrin degradation product (FDP) levels. The clinical scores of the skin, joints, abdomen, and kidneys were assessed during the acute and convalescence phases of HSP.

Results: The WBC count, ANC, ESR, and CRP, fibrinogen, D-dimer, and FDP levels were significantly higher in the acute phase compared with the convalescent phase of HSP (p<0.05). The total clinical scores were more strongly correlated with the D-dimer (r=0.371, p<0.001) and FDP (r=0.369, p<0.001) levels than with inflammatory markers, such as the WBC count (r=0.241, p=0.001), ANC (r=0.261, p<0.001), and CRP (r=0.260, p<0.001) levels. The patients with GI symptoms had significantly higher ANC (median [interquartile range], 7,138.0 [4,446.4-9,470.0] vs. 5,534.1 [3,263.0-8,153.5], p<0.05) and CRP (0.49 [0.15-1.38] vs. 0.23 [0.01-0.67], p<0.05), D-dimer (2.63 [1.20-4.09] vs. 1.75 [0.62-3.39]), and FDP (7.10 [0.01-13.65] vs. 0.10 [0.01-7.90], p<0.05) levels than those without GI symptoms.

Conclusion: D-dimer and FDPs are more strongly associated with disease activity and more consistently reflect GI involvement than inflammatory markers during the acute phase of HSP.

Keywords: Blood coagulation; Child; Fibrin fibrinogen degradation products; Fibrin fragment D; Inflammation; Purpura; Schönlein-Henoch.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Comparison of the levels of (A) fibrinogen, (B) D-dimer and (C) fibrin degradation products (FDPs) among the patients of acute phase, convalescent phase, and healthy controls. The fibrinogen, D-dimer, and FDP levels during the acute phase of the patients were significantly higher than during the convalescent phase and those in the control group (p<0.05).
Fig. 2
Fig. 2. Comparison of the levels of (A) white blood cell (WBC), (B) absolute neutrophil count (ANC), (C) C-reactive protein (CRP), (D) D-dimer, and (E) fibrin degradation products (FDPs) among the patients categorized according to the abdominal score of Henoch-Schönlein purpura. The ANC, CRP, D-dimer, and FDP levels were significantly higher in the patients with gastrointestinal (GI) symptoms (abdominal scores of 1-3) than those without GI symptoms (abdominal score of 0) (p<0.05). The patients with significant GI symptoms (abdominal scores of 2-3) had higher WBC counts, ANC, CRP, D-dimer, and FDP levels than those without GI symptoms (abdominal score of 0) (p<0.05). GI symptom: no, abdominal score 0; mild, abdominal score 1; significant, abdominal score 2-3.

References

    1. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114–1121. - PubMed
    1. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–941. - PMC - PubMed
    1. Kim S, Yoon J, Jeong S. Comparison of the clinical manifestations and prognosis of Henoch-Schonlein purpura in children with and without abdominal pain. Korean J Pediatr Gastroenterol Nutr. 2011;14:359–367.
    1. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum. 2005;35:143–153. - PubMed
    1. Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001;80:279–290. - PubMed